CIK 0001455365 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
COGNITION THERAPEUTICS INC
Sign in to watch- Ticker
- CGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 412-481-2210
- Business address
- 2500 WESTCHESTER AVE, PURCHASE, NY, 10577
- Former names
- COGNITION THERAPUTICS INC
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.13 ($11,300)
- 4 Open-market buy CEO & President bought 9,175 shares at $1.10 ($10,093)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.11 ($11,100)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 4 Shares withheld for taxes CEO & President gave up 5,850 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,560 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 4,680 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 77,740 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 26,921 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 38,407 shares (to pay taxes)
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 4 Shares withheld for taxes CEO & President gave up 23,400 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 20,280 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 9,360 shares (to pay taxes)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · Agreement ended
Page 2 of 16 · 303 filings